WHO ICTRP trial
Prospective study on the clinical efficacy of Darolutamide in non-metastatic…
JPRN-UMIN000040914 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000040914 |
|---|---|
| Public title | Prospective study on the clinical efficacy of Darolutamide in non-metastatic castration-resistant prostate cancer |
| Scientific title | Prospective study on the clinical efficacy of Darolutamide in non-metastatic castration-resistant prostate cancer - Prospective study on the clinical efficacy of Darolutamide in non-metastatic castration-resistant prostate cancer |
| Primary sponsor | Department of Urology, Gunma University Graduate School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | non-metastatic prostate cancer |
| Interventions | Darolutamide |
| Registration date | Jul 31, 2020 |
| Target size | 160 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: